Supernus Pharmaceuticals
SUPN
#4334
Rank
โ‚ฌ1.90 B
Marketcap
34,56ย โ‚ฌ
Share price
1.12%
Change (1 day)
35.96%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ36.4 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's total debt is โ‚ฌ36.4 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Supernus Pharmaceuticals - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ37.56 M-90.94%
2022-12-31โ‚ฌ0.41 B9.96%
2021-12-31โ‚ฌ0.37 B11.94%
2020-12-31โ‚ฌ0.33 B-0.29%
2019-12-31โ‚ฌ0.33 B17.3%
2018-12-31โ‚ฌ0.28 B
2017-12-31N/A-100%
2016-12-31โ‚ฌ3.95 M-38.89%
2015-12-31โ‚ฌ6.47 M-69.95%
2014-12-31โ‚ฌ21.56 M-13.42%
2013-12-31โ‚ฌ24.9 M43.87%
2012-12-31โ‚ฌ17.3 M-23.76%
2011-12-31โ‚ฌ22.7 M-59.73%
2010-12-31โ‚ฌ56.38 M7.71%
2009-12-31โ‚ฌ52.34 M-2.42%
2008-12-31โ‚ฌ53.64 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.38 B 948.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ29.69 B 81,465.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ49.04 B 134,620.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.29 B 39,160.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ34.11 B 93,604.30%๐Ÿ‡บ๐Ÿ‡ธ USA